Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Neuromuscular Block

Neuromuscular Block

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Neuromuscular Block

3 trials tracked for Neuromuscular Block: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 22 citations.

3Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 3
  1. Phase 4 Deep Versus Moderate Muscle Relaxation During Laparoscopic Donor Nephrectomy in Enhancing Postoperative Recovery Completed · 22 cited
  2. Phase 4 Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade? Completed
  3. Phase 4 Effects of Intravenous Lidocaine Associated With Magnesium Sulfate on the Cisatracurium-Induced Neuromuscular Block Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Sugammadex improves diaphragmatic excursion and reduces pulmonary complications in morbidly obese patients
Diabetes & Endocrinology RCT
Sugammadex improves diaphragmatic excursion and reduces pulmonary complications in morbidly obese patients Sugammadex Helps Obese Patients Breathe Easier
A randomized double-blind controlled trial in 104 morbidly obese patients compared sugammadex (2 mg/kg) with neostigmine+atropine.
This new research shows that a specific reversal drug helps morbidly obese patients breathe better and avoid lung issues after surgery.
Apr 14, 2026